137 results on '"Nagarajan, Arun"'
Search Results
2. Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer
3. Obesity and overweight are associated with worse survival in early-onset colorectal cancer
4. Microbe-induced coordination of plant iron–sulfur metabolism enhances high-light-stress tolerance of Arabidopsis
5. We Asked the Experts: Watch and Wait; Treatment of Rectal Cancer
6. Total Neoadjuvant Therapy Is a Predictor for Complete Pathological Response in Patients Undergoing Surgery for Rectal Cancer
7. Effect of neoadjuvant therapy regimens on lymph nodes yield in rectal cancer
8. Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database
9. Assessment of mesorectal fascia status in MRI compared with circumferential resection margin after total mesorectal excision and predictors of involved margins
10. Total neoadjuvant therapy: Fact, fantasy, or fallacy?
11. Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.
12. Mechanically Tunable Slippery Behavior on Soft Poly(dimethylsiloxane) (PDMS) Based Anisotropic Wrinkles Infused with Lubricating Fluid
13. Enhanced Slippery Behavior and Stability of Lubricating Fluid Infused Nanostructured Surfaces
14. Investigation of slippery behaviour of lubricating fluid coated smooth hydrophilic surfaces
15. Electrowetting on dielectrics on lubricating fluid based slippery surfaces with negligible hysteresis
16. Principles of Adjuvant and Neoadjuvant Therapy for Locally Advanced Rectal Cancer
17. Immunotherapy in rectal cancer patients—a propensity score matched analysis of the National Cancer Database
18. Practical and cost-effective model to build and sustain a cardio-oncology program
19. Principles of Adjuvant and Neoadjuvant Therapy for Locally Advanced Rectal Cancer
20. Data from E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma
21. Table S1, Table S2 from E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma
22. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
23. Liver Venous Deprivation for Rapid Liver Hypertrophy Before Major Hepatectomy: A Case Report
24. Ionic silver functionalized ovine forestomach matrix – a non-cytotoxic antimicrobial biomaterial for tissue regeneration applications
25. Liver Venous Deprivation for Rapid Liver Hypertrophy Before Major Hepatectomy: A Case Report
26. We Asked the Experts: Watch and Wait; Treatment of Rectal Cancer
27. The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship
28. The Urogenital System’s Role in Diseases: A Synopsis
29. Can CA 19-9 predict inferior surgical and pathological outcomes for resectable pancreatic cancer?
30. Medullary carcinoma of the colon: A comprehensive analysis of a large cancer database.
31. Further structural characterization of ovine forestomach matrix and multi-layered extracellular matrix composites for soft tissue repair
32. Biomarker Testing Disparities in Metastatic Colorectal Cancer.
33. Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?
34. Number of nonsynonymous genomic variants may correlate with prognosis in advanced pancreatic cancer.
35. Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience
36. Predictive Modeling of Microemulsion Phase Behaviour and Microstructure Characterisation in the 1-Phase Region
37. Further structural characterization of ovine forestomach matrix and multi-layered extracellular matrix composites for soft tissue repair.
38. E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma
39. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
40. Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience
41. A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611).
42. Electrowetting on dielectrics on lubricating fluid-infused smooth/rough surfaces with negligible hysteresis
43. Enhanced slippery behavior and stability of lubricating fluid infused nanostructured surfaces
44. Mechanically Tunable Slippery Behavior on Soft Poly(dimethylsiloxane)-Based Anisotropic Wrinkles Infused with Lubricating Fluid
45. A prospective, real-world study of treatment patterns in early-stage breast cancer (ESBC) patients (pts) at high risk for febrile neutropenia (FN).
46. Slipperiness and stability of hydrophilic surfaces coated with a lubricating fluid
47. Secondary Malignancies in Mantle Cell Lymphoma
48. A national analysis evaluating the role of neoadjuvant chemoradiotherapy in upper esophageal cancer.
49. Survival analysis comparing neoadjuvant chemoradiotherapy versus perioperative chemotherapy for locoregional gastric cancer.
50. Immunotherapy in locally advanced and metastatic rectal cancer: A propensity score matched analysis of the National Cancer Database.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.